leucomycin

Leucomycin (Turimycin) is a macrolide antibiotic.

Leucomycin a5 is a metabolite from the leucomycin complex, which was originally isolated from S. kitasatoensis. It is active against a variety of Gram-positive and Gram-negative bacteria (MICs = 0.04-0.8 µg/ml) but not against K. pneumoniae, S. typhimuriu

Leucomycin A13 is a macrolide antibiotic and a component of the leucomycin complex originally isolated from S. kitasatoensis. It is active against B. subtilis, S. aureus, M. luteus, and E. coli with MIC values of 0.16, 0.16, 0.08, and >10 μg/ml, respectively. It binds to ribosomes with an IC50 value of 1.2 μM in a radioligand binding assay.

Leucomycin A4 is a macrolide antibiotic that has been found in S. kitasatoensis. It is active against a variety of bacteria, including S. aureus, B. subtilis, C. diphtheriae, N. gonorrhoeae, and H. influenzae (MICs = 0.15, 1.25, 0.15, 0.6, and 0.15 μg/ml, respectively).

Leucomycin (Standard) is the standard substance of Leucomycin, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Leucomycin (Turimycin) is a macrolide antibiotic.

Leucomycin V is a macrolide antibiotic. Leucomycin A9 exhibits strong activity against Gram-positive bacteria and also affects spirochetes, rickettsiae, and chlamydiae.

Leucomycin U is a macrolide antibiotic. It demonstrates significant activity against Gram-positive bacteria and also exhibits effects on spirochetes, rickettsiae, and chlamydiae.

Leucomycin A6 effectively combats Gram-positive bacteria.

Leucomycin A9 is a macrolide antibiotic known for its potent activity against Gram-positive bacteria. It is also effective against spirochetes, rickettsiae, and chlamydiae.

Leucomycin A7 is a component of the leucomycin complex, isolated from *Streptomyces kitasatoensis*. It possesses antibacterial activity, effectively inhibiting the growth of gram-positive bacteria, while its inhibitory effect on gram-negative bacteria is comparatively weaker.

Leucomycin A8 is an antibiotic derived from Streptomyces kitasatoensis and is utilized in infection research.

Kitasamycin tartrate, a macrolide antibiotic produced by Streptomyces kitasatoensis, has a wide spectrum of antimicrobial activity.

Carbomycin B is an intermediate in the synthesis of Carbomycin. Carbomycin is a macrolite antibiotic complex produced by Stroptomyces halstedii, that is similar to Leucomycin and Erythromycin.

Josamycin HCl is a macrolide antibiotic.